DRUG TRANSPORT IN THE BRAIN - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 460

347. Gupta A, Zhang Y, Unadkat JD, Mao Q. 2004. HIV protease inhibitors are inhibitors
but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). J
Pharmacol Exp Ther 310:334-341.
348. Huang L, Wring SA, Woolley JL, Brouwer KR, Serabjit-Singh C, Polli JW. 2001.
Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitors. Drug
Metab Dispos 29:754-760.
349. Perloff MD, von Moltke LL, Marchand JE, Greenblatt DJ. 2001. Ritonavir induces
P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression,
and drug transporter-mediated activity in a human intestinal cell line. J Pharm Sci
90:1829-1837.
350. Dupuis ML, Flego M, Molinari A, Cianfriglia M. 2003. Saquinavir induces stable
and functional expression of the multidrug transporter P-glycoprotein in human CD4
T-lymphoblastoid CEMrev cells. HIV Med 4:338-345.
351. Chandler B, Almond L, Ford J, Owen A, Hoggard P, Khoo S, Back D. 2003. The
effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on
P-glycoprotein expression in peripheral blood mononuclear cells in vitro. J Acquir
Immune Defic Syndr 33:551-556.
352. Yusa K, Oh-hara T, Yamazaki A, Tsukahara S, Satoh W, Tsuruo T. 1990. Cross-resistance
to anti-HIV nucleoside analogs in multidrug-resistant human cells. Biochem Biophys
Res Commun 169:986-990.
353. Hong M, Schlichter L, Bendayan R. 2001. A novel zidovudine uptake system in
microglia. J Pharmacol Exp Ther 296:141-149.
354. Cano-Soldado P, Lorrayoz IM, Molina-Arcas M, Casado FJ, Martinez-Picado J, Lostao
MP, Pastor-Anglada M. 2004. Interaction of nucleoside inhibitors of HIV-1 reverse
transcriptase with the concentrative nucleoside transporter-1 (SLC28A1). Antivir Ther
9:993-1002.
355. Browne TR, Holmes GL. 2001. Epilepsy. N Engl J Med 344:1145-1151.
356. Kwan P, Brodie MJ. 2000. Epilepsy after the first drug fails: substitution or add-on?
Seizure 9:464-468.
357. Loscher W, Potschka H. 2005. Role of drug efflux transporters in the brain for drug
disposition and treatment of brain diseases. Prog Neurobiol 76:22-76.
358. Sisodiya SM. 2003. Mechanisms of antiepileptic drug resistance. Curr Opin Neurol
16:197-201.
359. Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C. 1995. MDR1
gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36:
1-6.
360. Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W, Mayberg
MR, Bengez L, Janigro D. 2001. Overexpression of multiple drug resistance genes in
endothelial cells from patients with refractory epilepsy. Epilepsia 42:1501-1506.
361. Rizzi M, Perego C, Aliprandi M, Richichi C, Ravizza T, Colella D, Veliskova J, Moshe
SL, De Simoni MG, Vezzani A. 2003. Glia activation and cytokine increase in rat
hippocampus by kainic acid-induced status epilepticus during postnatal development.
Neurobiol Dis 14:494-503.
362. Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M. 2002. Drug resistance in
epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.
Brain 125:22-31.